Literature DB >> 16776715

How does acantholysis occur in pemphigus vulgaris: a critical review.

Alessandro Lanza1, Nicola Cirillo, Felice Femiano, Fernando Gombos.   

Abstract

BACKGROUND: Pemphigus vulgaris is a life-threatening autoimmune blistering disease targeting skin and mucous membranes, characterized by disruption of keratinocytes' adhesion termed acantholysis. Today multiple classes of targets are considered to play a role in the genesis of the acantholysis; of these, the classical pemphigus antigens, desmosomal cadherins (desmoglein 1 and 3) are the best characterized and considered as the most important. Additional antigens include the novel epithelial acetylcholine receptors (alpha9 and pemphaxin). Thus, acantholysis in pemphigus seems to result from a cooperative action of antibodies to different keratinocyte self-antigens, but the mechanisms by which epithelial cleft occurs are not yet clearly understood. In fact, the binding of the autoantibodies to these targets generates a plethora of biological effects due, on one hand, to their direct interference with adhesive function and, on the other, to more complex events involving intracellular pathways that modify proteases activity or calcium metabolism, leading to loss of cell-cell adhesion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16776715     DOI: 10.1111/j.0303-6987.2006.00523.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  19 in total

Review 1.  What's new in blistering disorders?

Authors:  Paru Chaudhari; M Peter Marinkovich
Journal:  Curr Allergy Asthma Rep       Date:  2007-07       Impact factor: 4.806

2.  A novel method to investigate pemphigus-induced keratinocyte dysmorphisms through living cell immunofluorescence microscopy.

Authors:  Nicola Cirillo; Felice Femiano; Antonio Dell'Ermo; Pietro Arnese; Fernando Gombos; Alessandro Lanza
Journal:  Virchows Arch       Date:  2007-04-21       Impact factor: 4.064

3.  Desmosomal interactome in keratinocytes: a systems biology approach leading to an understanding of the pathogenesis of skin disease.

Authors:  Nicola Cirillo; Stephen S Prime
Journal:  Cell Mol Life Sci       Date:  2009-11       Impact factor: 9.261

4.  An unusual presentation of pemphigus vulgaris.

Authors:  Jesse P Houghton; Monica Ianosi-Irimie; Stacey B Trooskin; Hazar Michael
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-01

5.  Pemphigus vulgaris immunoglobulin G can recognize a 130 000 MW antigen other than desmoglein 3 on peripheral blood mononuclear cell surface.

Authors:  Nicola Cirillo; Fernando Gombos; Alessandro Lanza
Journal:  Immunology       Date:  2007-03-26       Impact factor: 7.397

6.  Pemphigus vulgaris IgG-induced desmoglein-3 endocytosis and desmosomal disassembly are mediated by a clathrin- and dynamin-independent mechanism.

Authors:  Emmanuella Delva; Jean Marie Jennings; Cathárine C Calkins; Margaret D Kottke; Victor Faundez; Andrew P Kowalczyk
Journal:  J Biol Chem       Date:  2008-04-23       Impact factor: 5.157

7.  Critical Role of the Neonatal Fc Receptor (FcRn) in the Pathogenic Action of Antimitochondrial Autoantibodies Synergizing with Anti-desmoglein Autoantibodies in Pemphigus Vulgaris.

Authors:  Yumay Chen; Alex Chernyavsky; Robert J Webber; Sergei A Grando; Ping H Wang
Journal:  J Biol Chem       Date:  2015-08-10       Impact factor: 5.157

8.  Pemphigus IgG causes skin splitting in the presence of both desmoglein 1 and desmoglein 3.

Authors:  Volker Spindler; Detlev Drenckhahn; Detlef Zillikens; Jens Waschke
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

9.  Micro-Raman spectroscopy and univariate analysis for monitoring disease follow-up.

Authors:  Carlo Camerlingo; Ines Delfino; Giuseppe Perna; Vito Capozzi; Maria Lepore
Journal:  Sensors (Basel)       Date:  2011-08-25       Impact factor: 3.576

Review 10.  The desmosome and pemphigus.

Authors:  Jens Waschke
Journal:  Histochem Cell Biol       Date:  2008-04-03       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.